Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $1.06 Million - $1.16 Million
11,462 New
11,462 $1.16 Million
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $9.92 Million - $11.7 Million
-118,837 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$78.07 - $94.43 $7.94 Million - $9.61 Million
101,732 Added 594.75%
118,837 $11.2 Million
Q1 2020

May 15, 2020

BUY
$70.67 - $99.01 $1.21 Million - $1.69 Million
17,105 New
17,105 $1.41 Million
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $6.6 Million - $7.46 Million
-78,195 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$85.54 - $94.26 $767,721 - $845,983
-8,975 Reduced 10.3%
78,195 $6.8 Million
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $1.72 Million - $1.97 Million
22,846 Added 35.52%
87,170 $8.38 Million
Q4 2018

Feb 14, 2019

BUY
$73.66 - $82.02 $4.74 Million - $5.28 Million
64,324 New
64,324 $5.52 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $230B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Susquehanna International Securities, Ltd. Portfolio

Follow Susquehanna International Securities, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Securities, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Securities, Ltd. with notifications on news.